Miquel Navasa

20.9k total citations · 4 hit papers
237 papers, 14.5k citations indexed

About

Miquel Navasa is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Miquel Navasa has authored 237 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Hepatology, 134 papers in Epidemiology and 102 papers in Surgery. Recurrent topics in Miquel Navasa's work include Liver Disease and Transplantation (138 papers), Liver Disease Diagnosis and Treatment (106 papers) and Organ Transplantation Techniques and Outcomes (84 papers). Miquel Navasa is often cited by papers focused on Liver Disease and Transplantation (138 papers), Liver Disease Diagnosis and Treatment (106 papers) and Organ Transplantation Techniques and Outcomes (84 papers). Miquel Navasa collaborates with scholars based in Spain, United States and United Kingdom. Miquel Navasa's co-authors include Antoni Rimola, Xavier Forns, Joan Rodés, Vicente Arroyo, Juan Rodés, Ramón Planas, Pere Ginès, Gonzalo Crespo, Javier Fernández and J.A. Carrión and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Miquel Navasa

232 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis

1999 1.1k citations Miquel Navasa, Vicente Arroyo et al. profile →
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document

2000 759 citations Antoni Rimola, Miquel Navasa et al. Journal of Hepatology profile →
Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

2002 699 citations Miquel Navasa, Jordi Colmenero et al. Hepatology profile →
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1993 625 citations Wladimiro Jiménez, Miquel Navasa et al. Gastroenterology profile →

Peers

Countries citing papers authored by Miquel Navasa

Since Specialization

Citations

This map shows the geographic impact of Miquel Navasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miquel Navasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miquel Navasa more than expected).

Fields of papers citing papers by Miquel Navasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miquel Navasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miquel Navasa. The network helps show where Miquel Navasa may publish in the future.

Co-authorship network of co-authors of Miquel Navasa

This figure shows the co-authorship network connecting the top 25 collaborators of Miquel Navasa. A scholar is included among the top collaborators of Miquel Navasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miquel Navasa. Miquel Navasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liver transplantation in Latin America: reality and challenges 2023 ·The Lancet Regional Health - Americas ·(unknown), (unknown), (unknown), (unknown), Roberto Hernandez‐Alejandro, Juan Pablo Arab, Isaac Ruiz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alan G. Contreras, Mário Reis Álvares‐da‐Silva, Manuel Mendizábal, Cláudia P. Oliveira, Miquel Navasa, Ignacio García‐Juárez	10
2	Liver and kidney transplantation in polycystic liver and kidney disease 2021 ·Gastroenterología y Hepatología (English Edition) ·(unknown), Lydia Sastre, Jordi Colmenero, Juan Carlos García‐Valdecasas, Constantino Fondevila, (unknown), Miquel Navasa	1
3	Monitoring of Donor‐Derived Cell‐Free DNA by Short Tandem Repeats: Concentration of Total Cell‐Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation 2021 ·Liver Transplantation ·(unknown), Célia Bádenas, Constantino Fondevila, Wladimiro Jiménez, Miquel Navasa, Joan Anton Puig‐Butillé, Merçè Brunet	26
4	Active Smoking Before Liver Transplantation in Patients with Alcohol Use Disorder: Risk Factors and Outcomes 2020 ·Journal of Clinical Medicine ·(unknown), Antoni Gual, Jordi Colmenero, (unknown), Anna Lligoña, Miquel Navasa, Gonzalo Crespo, (unknown), Hugo López‐Pelayo	6
5	Cost-Effectiveness of Sequential USE of ELF/ARFI Test Versus Biopsy to Assess Liver Fibrosis in Chronic HCV 2016 ·Value in Health ·(unknown), Laura Sampietro-Colom, (unknown), Wladimiro Jiménez, Áurea Mira, Miquel Navasa	1
6	HEV infection in two referral centers in Spain; epidemiology and clinical outcomes 2014 ·Journal of Clinical Virology ·Sabela Lens, L. Mensa, Martina Gambato, Patricia González, Xavier Torras, Germán Soriano, Josep Costa, (unknown), María‐Carlota Londoño, Zoe Mariñó, Miquel Navasa, Sofía Pérez‐del‐Pulgar, Xavier Forns	18
7	IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation 2014 ·Journal of Clinical Virology ·Carlos Fernández‐Carrillo, Mairene Coto‐Llerena, Patricia González, Gonzalo Crespo, L. Mensa, (unknown), Martina Gambato, Miquel Navasa, Xavier Forns, Sofía Pérez‐del‐Pulgar	5
8	Everolimus Based Immunosuppression in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 24 Month Results from a Randomized Controlled Trial 2013 ·Liver Transplantation ·Faouzi Saliba, Robert S. Brown, (unknown), Susanne Beckebaum, (unknown), Miquel Navasa, Gaohong Dong, Paula López–Sánchez, Frederik Nevens	3
9	Imaging of hepatitis C virus infection in liver grafts after liver transplantation 2013 ·Journal of Hepatology ·L. Mensa, Sofía Pérez‐del‐Pulgar, Gonzalo Crespo, (unknown), Carlos Fernández‐Carrillo, Mairene Coto‐Llerena, Rosa Miquel, Helena Allende, Lluı́s Castells, Miquel Navasa, Xavier Forns	4
10	Donor and Recipient IL28B Polymorphisms in HCV-Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation 2011 ·American Journal of Transplantation ·Mairene Coto‐Llerena, Sofía Pérez‐del‐Pulgar, Gonzalo Crespo, J.A. Carrión, Suzanna M. Martinez, J.M. Sánchez-Tapias, Jaume Martorell, Miquel Navasa, Xavier Forns	63
11	Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C 2010 ·Alimentary Pharmacology & Therapeutics ·Suzanna M. Martinez, Guillermo Fernández‐Varo, Patricia González, (unknown), Miquel Bruguera, Miquel Navasa, Wladimiro Jiménez, J.M. Sánchez-Tapias, Xavier Forns	84
12	Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome 2004 ·Hepatology ·Federico P. Gómez, Graciela Martínez‐Palli, Joan Albert Barberà, Josep Roca, Miquel Navasa, Robert Rodriguez-Roisín	101
13	Osteoporosis and Bone Mineral Metabolism Disorders in Cirrhotic Patients Referred for Orthotopic Liver Transplantation 1997 ·Calcified Tissue International ·Ana Monegal, Miquel Navasa, Núria Guañabens, Pilar Peris, Françesca Pons, M. Jesús Martínez de Osaba, Antoni Rimola, J Rodés, J Muñoz-Gómez	162
14	Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study 1995 ·Hepatology ·Antoni Rimola, Joan Manuel Salmerón, G. Clemente, Luı́s Rodrigo, Antoni Obrador, María Luisa Miranda, Carlos Guarner, Ramón Planas, Ricard Solà, Vı́ctor Vargas, Fernando Casafont, Francesc Marco, Miquel Navasa, Rafael Bañares, Vicente Arroyo, J Rodés	131
15	A Cluster of Fever and Hypotension on a Surgical Intensive Care Unit Related to the Contamination of Plasma Expanders by Cell Wall Products of Bacillus stearothermophilus 1995 ·Infection Control and Hospital Epidemiology ·Antoni Trilla, Carles Codina, (unknown), Josep M. Gatell, (unknown), Francesc Marco, Miquel Navasa, J. Mulet, J. Ribas, M. T. Jiménez de Anta, (unknown)	2
16	Portal hypertension in acute liver failure. 1992 ·Gut ·Miquel Navasa, Juan Carlos García‐Pagán, Jaime Bosch, (unknown), Rafael Bañares, Antoni Mas, Miquel Bruguera, Joan Rodés	39
17	The use of the University of Wisconsin (UW) and Euro-Collins (EC) solutions either alone or in a combined method 1992 ·Transplant International ·(unknown), (unknown), Luís Grande, A. Rimola, Miquel Navasa, Josep Fuster, Antonio M. Lacy, Esteban Cugat, Josep Visa	10
18	Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis 1989 ·Gastroenterology ·Miquel Navasa, J Chesta, Jaume Bosch, Joan Rodés	47
19	Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis 1989 ·Gastroenterology ·Miquel Navasa, J Chesta, Jaime Bosch, J Rodés	126
20	Relapsing Polychondritis with Segmental Necrotizing Glomerulonephritis 1984 ·American Journal of Nephrology ·A Botey, Miquel Navasa, (unknown), J Montolíu, O. Ferrer‐Roca, Antonio Cardesa, A Darnell, L Revert	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact